Salusins: Potential use as a biomarker for atherosclerotic cardiovascular diseases

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Sato, Kengo ^a   Watanabe, Rena ^a   Itoh, Fumiko ^a   Shichiri, Masayoshi ^b   Watanabe, Takuya ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ARGIPRESSIN; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; OXYTOCIN; PEPTIDES AND PROTEINS; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SALUSIN ALPHA; SALUSIN BETA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BRADYCARDIA; CELL ADHESION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLINERGIC SYSTEM; CORONARY ARTERY; DISEASE ASSOCIATION; DISEASE MARKER; FIBROBLAST; FOAM CELL; HEMODYNAMICS; HORMONE RELEASE; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INOTROPISM; MACROPHAGE MIGRATION; NEOINTIMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

EID: 84887463593     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/965140     Document Type: Review

References (48)

1. Hochholzer W., Morrow D. A., Giugliano R. P., Novel biomarkers in cardiovascular disease: update 2010. American Heart Journal 2010 160 4 583 594 2-s2.0-77957831897 10.1016/j.ahj.2010.06.010
2. Abd T. T., Eapen D. J., Bajpai A., Goyal A., Dollar A., Sperling L., The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Current Atherosclerosis Reports 2011 13 2 154 161 2-s2.0-79955901873 10.1007/s11883-011-0164-5
3. Watanabe T., Sato K., Itoh F., Fujimoto K., Koyama T., Shichiri M., Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases. Current Protein and Peptide Science 2013 14 6 472 480
4. Watanabe T., Sato K., Itoh F., Wakabayashi K., Shichiri M., Hirano T., Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease. Sensors 2012 12 4 4974 4985 2-s2.0-84860133799 10.3390/s120404974
5. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A. E., Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001 103 15 1955 1960 2-s2.0-0035901582 (Pubitemid 32322222)
6. Watanabe T., Arita S., Shiraishi Y., Suguro T., Sakai T., Hongo S., Miyazaki A., Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases. Current Medicinal Chemistry 2009 16 5 550 563 2-s2.0-63149139105 10.2174/092986709787458515
7. Watanabe T., Koba S., Roles of serotonin in atherothrombosis and related diseases. Traditional and Novel Risk Factors in Atherothrombosis 2012 57 70
8. von Eynatten M., Humpert P. M., Bluemm A., Lepper P. M., Hamann A., Allolio B., Nawroth P. P., Bierhaus A., Dugi K. A., High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008 199 1 123 128 2-s2.0-45249083408 10.1016/j.atherosclerosis.2007.10.002 (Pubitemid 351842696)
9. 1 on macrophage foam cell formation and atherosclerosis. Circulation Research 2009 105 5 500 510 2-s2.0-70149110196 10.1161/CIRCRESAHA.109.193870
10. Watanabe T., Kanome T., Miyazaki A., Katagiri T., Human urotensin II as a link between hypertension and coronary artery disease. Hypertension Research 2006 29 6 375 387 2-s2.0-33746319906 10.1291/hypres.29.375 (Pubitemid 44102804)
11. Kanome T., Watanabe T., Nishio K., Takahashi K., Hongo S., Miyazaki A., Angiotensin II upregulates acyl-CoA: cholesterol acyltransferase-1 via the angiotensin II type 1 receptor in human monocyte-macrophages. Hypertension Research 2008 31 9 1801 1810 2-s2.0-55449106868
12. Suguro T., Watanabe T., Kanome T., Kodate S., Hirano T., Miyazaki A., Adachi M., Serotonin acts as an up-regulator of acyl-coenzyme A: cholesterol acyltransferase-1 in human monocyte-macrophages. Atherosclerosis 2006 186 2 275 281 2-s2.0-33646402051 10.1016/j.atherosclerosis.2005.08.007
13. Watanabe T., Pakala R., Katagiri T., Benedict C. R., Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation. Journal of Hypertension 2001 19 6 1065 1073 2-s2.0-0034997939 10.1097/00004872-200106000-00011 (Pubitemid 32493640)
14. Watanabe T., Pakala R., Katagiri T., Benedict C. R., Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 2001 104 1 16 18 2-s2.0-0035800017 (Pubitemid 32623283)
15. Watanabe T., Suguro T., Kanome T., Sakamoto Y.-I., Kodate S., Hagiwara T., Hongo S., Hirano T., Adachi M., Miyazaki A., Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005 46 4 738 744 2-s2.0-31944451269 10.1161/01.HYP.0000184226.99196.b5 (Pubitemid 43186747)
16. Watanabe T., Sato K., Itoh F., Iso Y., Nagashima M., Hirano T., Shichiri M., The roles of salusins in atherosclerosis and related cardiovascular diseases. Journal of the American Society of Hypertension 2011 5 5 359 365 2-s2.0-80053010542 10.1016/j.jash.2011.06.003
17. Shichiri M., Ishimaru S., Ota T., Nishikawa T., Isogai T., Hirata Y., Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nature Medicine 2003 9 9 1166 1172 2-s2.0-0141684566 10.1038/nm913 (Pubitemid 37173701)
18. Wang Z., Takahashi T., Saito Y., Nagasaki H., Ly N. K., Nothacker H.-P., Reinscheid R. K., Yang J., Chang J. K., Shichiri M., Civelli O., Salusin β is a surrogate ligand of the mas-like G protein-coupled receptor MrgA1. European Journal of Pharmacology 2006 539 3 145 150 2-s2.0-33646883475 10.1016/j.ejphar.2006.03.064 (Pubitemid 43783522)
19. Suzuki N., Shichiri M., Tateno T., Sato K., Hirata Y., Distinct systemic distribution of salusin- α and salusin- β in the rat. Peptides 2011 32 4 805 810 2-s2.0-79952819351 10.1016/j.peptides.2010.12.012
20. Suzuki N., Shichiri M., Akashi T., Sato K., Sakurada M., Hirono Y., Yoshimoto T., Koyama T., Hirata Y., Systemic distribution of salusin expression in the rat. Hypertension Research 2007 30 12 1255 1262 2-s2.0-38749133783 10.1291/hypres.30.1255 (Pubitemid 351176424)
21. Sahin I., Aydin S., Serum concentration and kidney expression of salusin- α and salusin- β in rats with metabolic syndrome induced by fructose. Biotechnic & Histochemistry 2013 88 3-4 153 160
22. Sato K., Sato T., Susumu T., Koyama T., Shichiri M., Presence of immunoreactive salusin- β in human plasma and urine. Regulatory Peptides 2009 158 1-3 63 67 2-s2.0-70349748261 10.1016/j.regpep.2009.07.017
23. Sato K., Koyama T., Tateno T., Hirata Y., Shichiri M., Presence of immunoreactive salusin- α in human serum and urine. Peptides 2006 27 11 2561 2566 2-s2.0-33750043499 10.1016/j.peptides.2006.06.005 (Pubitemid 44584413)
24. Sato K., Koyama T., Shichiri M., Biosynthesis and secretion of salusin- α from human cells. Peptides 2008 29 12 2203 2207 2-s2.0-55949131418 10.1016/j.peptides.2008.08.015 (Pubitemid 50287236)
25. Aydin S., Eren M. N., Ozercan I. H., Dagli A. F., The bioactive peptides salusins and apelin-36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass. Peptides 2012 37 2 233 239 10.1016/j.peptides.2012.07.027
26. Takenoya F., Hori T., Kageyama H., Funahashi H., Takeuchi M., Kitamura Y., Shichiri M., Shioda S., Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system. Neuroscience Letters 2005 385 2 110 113 2-s2.0-21844440015 10.1016/j.neulet.2005.05.061 (Pubitemid 40961645)
27. 2+]i increase and neurohypophyseal hormone release from the axon terminals. Journal of Neuroendocrinology 2008 20 2 207 219 2-s2.0-38649091360 10.1111/j.1365-2826.2007.01632.x (Pubitemid 351164224)
28. Izumiyama H., Tanaka H., Egi K., Sunamori M., Hirata Y., Shichiri M., Synthetic salusins as cardiac depressors in rat. Hypertension 2005 45 3 419 425 2-s2.0-14644430996 10.1161/01.HYP.0000156496.15668.62 (Pubitemid 40315812)
29. Chen W. W., Sun H. J., Zhang F., Salusin- β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats. Cardiovascular Research 2013 98 3 344 351 10.1093/cvr/cvt031
30. Yu F., Zhao J., Yang J., Gen B., Wang S., Feng X., Tang C., Chang L., Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regulatory Peptides 2004 122 3 191 197 2-s2.0-5644227771 10.1016/j.regpep.2004.06.013 (Pubitemid 39371169)
31. Xiao-Hong Y., Li L., Yan-Xia P., Hong L., Wei-Fang R., Yan L., An-Jing R., Chao-Shu T., Wen-Jun Y., Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. Journal of Cardiovascular Pharmacology 2006 48 2 41 46 2-s2.0-33748512583 10.1097/01.fjc.0000242059.89430.ac (Pubitemid 44358893)
32. Ren A. J., Liang Q., Wang R., Effects of salusin- β on action potential and ionic currents in ventricular myocytes of rats. Acta Physiologica 2013 207 1 166 172 10.1111/j.1748-1716.2012.02475.x
33. Shi J.-S., Li D., Li N., Lin L., Yang Y.-J., Tang Y., Sun T., Yuan W.-J., Ren A.-J., Inhibition of L-type calcium currents by salusin- β in rat cardiac ventricular myocytes. Peptides 2010 31 6 1146 1149 2-s2.0-77952109708 10.1016/j.peptides.2010.03.016
34. Shichiri M., Reply to 'salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities'. Nature Medicine 2007 13 6 661 662 2-s2.0-34249991745 10.1038/nm0607-661b (Pubitemid 46889741)
35. Fujimoto K., Hayashi A., Kamata Y., Circulating levels of human salusin- β a potent hemodynamic and atherogenesis regulator. PLoS One, vol. 8, no. 10, pp. e76714, 2013
36. Koya T., Miyazaki T., Watanabe T., Salusin- β saccelerates inflammatory responses in vascular endothelial cells via NF- B signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. The American Journal of Physiology: Heart and Circulatory Physiology 2012 303 1 H96 H105 10.1152/ajpheart.00009.2012
37. Watanabe T., Nishio K., Kanome T., Matsuyama T.-A., Koba S., Sakai T., Sato K., Hongo S., Nose K., Ota H., Kobayashi Y., Katagiri T., Shichiri M., Miyazaki A., Impact of salusin- α and-β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008 117 5 638 648 2-s2.0-40149089744 10.1161/CIRCULATIONAHA.107.712539
38. Shichiri M., Kato H., Marumo F., Hirata Y., Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 1997 30 5 1198 1203 2-s2.0-0030667291 (Pubitemid 27476179)
39. Shichiri M., Yokokura M., Marumo F., Hirata Y., Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 4 989 997 2-s2.0-0034031776 (Pubitemid 30207572)
40. Shimizu K., Tanaka H., Sunamori M., Marumo F., Shichiri M., Adrenomedullin receptor antagonism by calcitonin gene-related peptide(8-37) inhibits carotid artery neointimal hyperplasia after balloon injury. Circulation Research 1999 85 12 1199 1205 2-s2.0-0033533987 (Pubitemid 30430626)
41. Zhou C.-H., Liu L.-L., Wu Y.-Q., Song Z., Xing S.-H., Enhanced expression of salusin- β contributes to progression of atherosclerosis in LDL receptor deficient mice. Canadian Journal of Physiology and Pharmacology 2012 90 4 463 471 2-s2.0-84859148904 10.1139/Y2012-022
42. Nagashima M., Watanabe T., Shiraishi Y., Morita R., Terasaki M., Arita S., Hongo S., Sato K., Shichiri M., Miyazaki A., Hirano T., Chronic infusion of salusin- α and-β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 2010 212 1 70 77 2-s2.0-77956227663 10.1016/j.atherosclerosis.2010.04.027
43. Masumura M., Watanabe R., Nagashima A., Anti-salusin- β antibody enhances angiogenesis after myocardial ischemia reperfusion injury. Expert Opinion on Therapeutic Targets 2013 17 9 1003 1009 10.1517/14728222.2013.819852
44. Du S. L., Wang W. J., Wan J., Wang Y. G., Wang Z. K., Zhang Z., Serum salusin- α levels are inversely correlated with the presence and severity of coronary artery disease. Scandinavian Journal of Clinical & Laboratory Investigation 2013 73 4 339 343
45. Kimoto S., Sato K., Watanabe T., Suguro T., Koyama T., Shichiri M., Serum levels and urinary excretion of salusin- α in renal insufficiency. Regulatory Peptides 2010 162 1-3 129 132 2-s2.0-77952669439 10.1016/j.regpep. 2010.03.009
46. Watanabe T., Suguro T., Sato K., Koyama T., Nagashima M., Kodate S., Hirano T., Adachi M., Shichiri M., Miyazaki A., Serum salusin- α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertension Research 2008 31 3 463 468 2-s2.0-42649139281 10.1291/hypres.31.463 (Pubitemid 351597499)
47. Ti Y., Wang F., Wang Z.-H., Wang X.-L., Zhang W., Zhang Y., Bu P.-L., Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension. Journal of Human Hypertension 2012 26 10 603 609 2-s2.0-81155159177 10.1038/jhh.2011.71
48. Nakayama C., Shichiri M., Sato K., Hirata Y., Expression of prosalusin in human neuroblastoma cells. Peptides 2009 30 7 1362 1367 2-s2.0-67349130574 10.1016/j.peptides.2009.03.021